Navigation Links
BUSM researchers to study vitamin D production in fat malabsorption patients
Date:9/23/2010

(Boston) - Boston University School of Medicine (BUSM) researchers have been awarded a Small Business Technology Transfer (STTR) phase 1 award to develop and test a newly designed fluorescent lamp that is capable of producing vitamin D in the skin. Dr. Michael Holick, a professor of medicine, physiology and biophysics at BUSM and director of the General Clinical Research Unit, the Bone Health Clinic, and the Heliotherapy Light and Skin Research Center, is the principal investigator of the study. Holick believes that exposure to this newly designed indoor portable fluorescent ultraviolet irradiation device will be a cost effective way to satisfy the vitamin D requirement for patients with fat malabsorption syndromes. Dr. Francis Farraye, a professor of medicine at BUSM and Clinical Director in the Gastroenterology Section at Boston Medical Center, is the co-investigator. The researchers have partnered with a KBD Inc. on this project.

According to the researchers, they will immediately begin recruiting patients with fat malabsorption syndromes including patients with Crohn's disease and bypass surgery to participate in the study. Study participants will receive a fluorescent light device and be taught how to use it. After the training they will take the lamp home and expose their abdomen, legs or back to the vitamin D producing lamp three times a week. After three months, the researchers will measure their blood levels of 25-hydroxyvitamin D to determine the effectiveness of the lamp in producing vitamin D in the skin.

Initial results should be available in the spring of 2011.


'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Page: 1

Related biology news :

1. NC State researchers get to root of parasite genome
2. Researchers find animal with ability to survive climate change
3. Researchers find an essential gene for forming ears of corn
4. Researchers note differences between people and animals on calorie restriction
5. Researchers study acoustic communication in deep-sea fish
6. Researchers discover that growing up too fast may mean dying young in honey bees
7. Researchers study how pistachios may improve heart health
8. UI researchers find potentially toxic substance present in Chicago air
9. Researchers develop new self-training gene prediction program for fungi
10. Case Western Reserve University researchers track Chernobyl fallout
11. Childrens National researchers develop novel anti-tumor vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/2/2016)... , June 2, 2016 The ... has awarded the 44 million US Dollar project, for ... Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... leader in the production and implementation of Identity Management Solutions. ... January, however Decatur was selected for ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: